CHE

Business Context and Reporting Period

Company: Chemed Corporation (CHE)

Filing Type: Form 10-Q (Unaudited)

Reporting Period: Quarter and six months ended June 30, 2025

Chemed Corporation operates through two primary segments: VITAS Healthcare, a national provider of hospice care, and Roto-Rooter, a provider of plumbing, drain cleaning, excavation, and water restoration services. The company is a large accelerated filer with operations primarily located in the United States.

Key Financial Metrics

Margins (Q2 2025 vs Q2 2024):

• Consolidated Gross Margin: 29.8% (down from 34.6%)
• VITAS Gross Margin: 19.1% (down from 23.8%)
• Roto-Rooter Gross Margin: 49.0% (down from 52.9%)

Material Changes vs. Prior Period

Revenue Growth: Consolidated revenue increased 3.8% in Q2 2025 and 6.8% for the six-month period.

• VITAS: Revenue grew 5.8% in Q2, driven by a 6.1% increase in days-of-care and a 4.2% increase in Medicare reimbursement rates. Growth was partially offset by a significant increase in the Medicare Cap liability ($16.4 million in Q2 vs. $1.4 million in Q2 2024).
• Roto-Rooter: Revenue grew 0.6% in Q2. Growth in excavation and water restoration (driven by weather-related demand) offset declines in drain cleaning and plumbing job counts.

Profitability Decline: Net income decreased 26% in Q2 and 8.6% for the six months ended June 30, 2025.

• VITAS: Earnings were negatively impacted by the $15.0 million increase in Medicare Cap liability compared to the prior year.
• Roto-Rooter: Earnings were reduced by a $4.9 million increase in casualty insurance expense and higher variable costs.

Balance Sheet Movements:

• Other Assets: Decreased by $47.4 million, primarily due to the refund of a $47.0 million deposit previously held with the Office of Audit Services (OAS) following a favorable Administrative Law Judge ruling.
• Accounts Receivable: Increased by $13.7 million due to the timing of federal government payments.
• Accrued Compensation: Decreased by $37.4 million due to the payment of 2024 bonuses in Q1 2025 and lower accrual rates in 2025.

Guidance, Outlook, and Risks

Management Commentary:

• Tariffs and Inflation: Management monitors macroeconomic trends, including tariffs and inflation. Preliminary analysis suggests no material negative effect on net sales or profitability for the remainder of fiscal 2025, though cost increases may impact 2026 planning.
• Capital Allocation: The company continues to evaluate share repurchases, dividends, and acquisitions. $182.6 million remains available under the current share repurchase authorization.

Risks and Contingencies:

• Regulatory Matters: VITAS remains subject to audits and investigations by government agencies. The company successfully resolved a significant OAS audit regarding elevated level-of-care services, resulting in a refund of the majority of the disputed amount.
• Medicare Cap: The company faces ongoing exposure to Medicare annual per-beneficiary caps, which significantly impacted Q2 revenue recognition.
• Executive Departure: On July 29, 2025, Nicholas M. Westfall departed as VITAS Chairman and CEO. A transition agreement was entered into with severance and benefit provisions.

Investor Verification Checklist

• Medicare Cap Impact: Verify the sustainability of the $16.4 million Medicare Cap adjustment in Q2 and its projected impact on the remainder of 2025.
• Insurance Costs: Assess the trajectory of casualty insurance expenses for Roto-Rooter, which increased significantly in Q2.
• Regulatory Resolution: Confirm the final status of the OAS audit refund and ensure no further liabilities remain from the $140 million initial recommendation.
• Executive Transition: Monitor the integration of new leadership at VITAS following the departure of the CEO.
• Job Count Trends: Evaluate the decline in Roto-Rooter's drain cleaning and plumbing job counts against the increase in water restoration demand to understand underlying market dynamics.